Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease
- Conditions
- Inflammatory Bowel DiseaseChronic Granulomatous Disease
- Interventions
- Other: Neocate Splash
- First Posted Date
- 2019-06-12
- Last Posted Date
- 2024-11-27
- Target Recruit Count
- 10
- Registration Number
- NCT03983837
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2022-06-07
- Target Recruit Count
- 48
- Registration Number
- NCT03978091
- Locations
- 🇺🇸
Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit, Durham, North Carolina, United States
Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2019-05-29
- Last Posted Date
- 2024-07-05
- Target Recruit Count
- 1105
- Registration Number
- NCT03965923
- Locations
- 🇺🇬
MU-JHU Research Collaboration (MUJHU CARE LTD) CRS, Kampala, Uganda
🇿🇦Wits RHI Shandukani Research Centre CRS, Johannesburg, Gauteng, South Africa
🇲🇼Blantyre CRS (Johns Hopkins Research Project/College of Medicine), Blantyre, Malawi
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...
- Conditions
- Malaria
- Interventions
- Biological: PfSPZ ChallengeDrug: Chloroquine PhosphateDrug: PyrimethamineDrug: CoartemDrug: ibuprofen
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2022-07-12
- Target Recruit Count
- 252
- Registration Number
- NCT03952650
- Locations
- 🇲🇱
Malaria Vaccine Center STTB/MRTC, Bamako, Mali
Belimumab With Rituximab for Primary Membranous Nephropathy
- Conditions
- Membranous NephropathyNephrotic Syndrome
- Interventions
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2024-11-06
- Target Recruit Count
- 58
- Registration Number
- NCT03949855
- Locations
- 🇨🇦
Centre de recherche de l'Hôpital Maisonneuve-Rosemont Nephrology Department, Montréal, Quebec, Canada
🇺🇸University of Alabama at Birmingham School of Medicine: Division of Nephrology, Birmingham, Alabama, United States
🇺🇸University of Arkansas, Little Rock, Arkansas, United States
Flublok or Fluzone With Advax-CpG55.2 or AF03
- Conditions
- InfluenzaInfluenza Immunisation
- Interventions
- Biological: Influenza Virus Quadrivalent Inactivated VaccineDrug: AF03Biological: Delta Inulin-CpG55.2Biological: Quadrivalent Recombinant Seasonal Influenza Vaccine
- First Posted Date
- 2019-05-10
- Last Posted Date
- 2024-04-01
- Target Recruit Count
- 241
- Registration Number
- NCT03945825
- Locations
- 🇺🇸
University of Maryland Baltimore - School of Medicine - Medicine, Baltimore, Maryland, United States
🇺🇸Duke Vaccine and Trials Unit, Durham, North Carolina, United States
🇺🇸Cincinnati Children's Hospital Medical Center Vaccine Research Center, Cincinnati, Ohio, United States
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- Conditions
- Sickle Cell DiseaseAlpha and Beta ThalassemiaMalariaHuman Physiology
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 300
- Registration Number
- NCT03937817
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants
- Conditions
- HIV Infections
- Interventions
- Biological: Placebo for MPER-656 Liposome VaccineBiological: MPER-656 Liposome Vaccine
- First Posted Date
- 2019-05-02
- Last Posted Date
- 2022-07-06
- Target Recruit Count
- 24
- Registration Number
- NCT03934541
- Locations
- 🇺🇸
Alabama CRS, Birmingham, Alabama, United States
🇺🇸Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States
🇺🇸Columbia P&S CRS, New York, New York, United States
Suppression Of Bacterial Vaginosis (BV) [SUBVert]
- Conditions
- Bacterial Vaginosis
- Interventions
- Drug: TOL-463Other: Placebo
- First Posted Date
- 2019-04-29
- Last Posted Date
- 2023-02-22
- Target Recruit Count
- 81
- Registration Number
- NCT03930745
- Locations
- 🇺🇸
University of California, San Diego - Antiviral Research Center, La Jolla, California, United States
🇺🇸University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States
🇺🇸Magee Women's Hospital of UPMC - Reproductive Infectious Disease Research, Pittsburgh, Pennsylvania, United States
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants
- Conditions
- HIV Infections
- Interventions
- Biological: PGT121Biological: PGDM1400Biological: 10-1074Biological: VRC07-523LS
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2022-07-11
- Target Recruit Count
- 27
- Registration Number
- NCT03928821
- Locations
- 🇺🇸
Columbia P&S CRS, New York, New York, United States
🇺🇸Harlem Prevention Center CRS, New York, New York, United States
🇺🇸Vanderbilt Vaccine (VV) CRS, Nashville, Tennessee, United States